[
    {
        "generic_name": "Pravastatin",
        "brand_name": "APLACTIN",
        "disease_name": "Hypercholesterolemia||Mixed dyslipidemia||Cardiovascular disease||Myocardial infarction||Unstable angina pectoris||Hyperlipidemia (post-transplant)",
        "indication": "high cholesterol||high blood fat||prevention of cardiovascular events||history of myocardial infarction||unstable angina||post-transplant hyperlipidemia",
        "active_ingredients": "Pravastatin sodium salt",
        "pharmaceutical_form": "tablet",
        "manufacturer": "",
        "administration_route": "oral",
        "recommended_usage": "take with or without food||at fixed time",
        "single_dose": "adults 10-40 mg once a day||cardiovascular prevention 40 mg per day||post-transplant (immunosuppressive therapy) 20 mg per day (up to 40 mg)||renal or hepatic insufficiency 10 mg per day",
        "dosage_frequency": "once daily",
        "mechanism_of_action": "competitive inhibition of HMG-CoA reductase, reduces cholesterol synthesis, increases LDL receptor expression, increases LDL catabolism, inhibits VLDL synthesis",
        "side_effects": "muscle pain||joint pain||muscle cramps||muscle weakness||elevated creatine kinase||increased liver enzymes||dizziness||headache||sleep disturbances||insomnia||nightmares||vision disturbances||blurred vision||double vision||digestive disorders||abdominal pain||nausea||vomiting||constipation||diarrhea||bloating||itching||rash||hives||hair changes||hair loss||difficulty urinating||frequent urination||nocturia||peripheral polyneuropathy||paraesthesia||anaphylaxis||angioedema||lupus erythematosus-like syndrome||jaundice||hepatitis||fulminant hepatic necrosis||rhabdomyolysis||myopathy||interstitial lung disease||diabetes mellitus||dermatomyositis",
        "activation_conditions": "no special condition",
        "prescription_status": "prescription_only",
        "unsuitable_population": "children under 18||pregnant women||breastfeeding women||patients with active liver disease||patients with persistent elevated transaminases||patients with hereditary problems of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption",
        "storage_conditions": "store at room temperature"
    },
    {
        "generic_name": "methylphenidate HCl",
        "brand_name": "Concerta",
        "disease_name": "Attention Deficit Hyperactivity Disorder",
        "indication": "inattentive ADHD||impulsivity||hyperactive behavior||behavior problems||difficulty paying attention||difficulty staying focused||difficulty organizing tasks||difficulty listening",
        "active_ingredients": "methylphenidate HCl",
        "pharmaceutical_form": "capsule",
        "manufacturer": "Janssen Pharmaceuticals",
        "administration_route": "oral",
        "recommended_usage": "swallowed with water||take with or without food||at fixed time",
        "single_dose": "children and adolescents up to 54mg daily||adults up to 72mg daily",
        "dosage_frequency": "once daily",
        "mechanism_of_action": "changing the amounts of certain natural substances in the brain",
        "side_effects": "decreased appetite||dry mouth||sleep disruption||dizziness||stomach ache||increased sweating||headache||nausea||anxiety||weight loss||irritability||slowing of growth in children||seizures||priapism||eyesight changes||blurred vision",
        "activation_conditions": "",
        "prescription_status": "prescription_only",
        "unsuitable_population": "children under 6||patients with allergy or hypersensitivity to methylphenidate HCI||patients with anxiety||patients with glaucoma||patients with tics or history of Tourette’s syndrome||patients taking monoamine oxidase inhibitors (MAOIs)||patients with heart or mental problems||patients with seizures||patients with abnormal brain wave tests||patients with circulation problems||patients with esophagus, stomach or intestine problems||pregnant women||nursing mothers",
        "storage_conditions": "store at room temperature||store in a secure place out of the reach of children"
    },
    {
        "generic_name": "Amlodipine",
        "brand_name": "Norvasc",
        "disease_name": "Coronary artery disease||Hypertension||Angina||Myocardial infarction",
        "indication": "High blood pressure||Chest pain||Cardiovascular events",
        "active_ingredients": "Amlodipine",
        "pharmaceutical_form": "tablet||suspension",
        "manufacturer": "",
        "administration_route": "oral",
        "recommended_usage": "take with or without food||at fixed time",
        "single_dose": "adults 5 mg||adults 10 mg||children over 6 years 2.5 mg||children over 6 years 5 mg",
        "dosage_frequency": "once daily",
        "mechanism_of_action": "Dilates blood vessels and reduces peripheral vascular resistance",
        "side_effects": "Dizziness||Edema||Palpitation||Drowsiness||Nausea||Headache||Fainting||Irregular heartbeat||Rapid heartbeat||Chest pain",
        "activation_conditions": "no special condition",
        "prescription_status": "prescription_only",
        "unsuitable_population": "children under 6 years||breastfeeding women",
        "storage_conditions": "store at room temperature||keep tightly closed||keep in a dry place||protect from light"
    },
    {
        "generic_name": "Isoniazid",
        "brand_name": "Isokin",
        "disease_name": "Human immunodeficiency virus infection||diabetes mellitus||gastrointestinal disorders||peptic ulcers||tuberculosis||Mycobacteria kansasii infection||Mycobacteria xenopi infection",
        "indication": "preventive treatment of bacterial infections",
        "active_ingredients": "Isoniazid",
        "pharmaceutical_form": "tablet||injection||syrup",
        "manufacturer": "Pfizer Laboratories Limited",
        "administration_route": "oral",
        "recommended_usage": "take with or without food||swallowed with water",
        "single_dose": "adults 300 mg",
        "dosage_frequency": "once daily",
        "mechanism_of_action": "blocking the cell wall synthesis",
        "side_effects": "severe complications",
        "activation_conditions": "no special condition",
        "prescription_status": "prescription_only",
        "unsuitable_population": "pregnant women||elderly people||patients with nephropathy||patients with neuropathy||patients with cardiovascular disorders",
        "storage_conditions": ""
    },
    {
        "generic_name": "Stavudine",
        "brand_name": "ZERIT",
        "disease_name": "HIV infection||AIDS",
        "indication": "HIV infection",
        "active_ingredients": "Stavudine",
        "pharmaceutical_form": "capsule||solution",
        "manufacturer": "",
        "administration_route": "oral",
        "recommended_usage": "at fixed time",
        "single_dose": "newborns 0.5 mg/kg/dose || pediatric patients <30 kg 1 mg/kg/dose || pediatric patients ≥30 kg adult dosage || adults ≥60 kg 20 mg || adults <60 kg 15 mg",
        "dosage_frequency": "every 12 hours||every 24 hours",
        "mechanism_of_action": "nucleoside reverse transcriptase inhibitor",
        "side_effects": "peripheral neuropathy||headache||diarrhea||rash||nausea||vomiting||abdominal pain||muscle pain||insomnia||loss of appetite||chills||fever||allergic reactions||blood disorders||hyperglycemia||diabetes||pancreatitis||lactic acidosis||hepatotoxicity||redistribution/accumulation of body fat||severe motor weakness",
        "activation_conditions": "no special condition",
        "prescription_status": "prescription_only",
        "unsuitable_population": "patients with pancreatitis||patients with hepatic decompensation||patients with severe peripheral neuropathy||pregnant women (with caution)||patients with history of lactic acidosis",
        "storage_conditions": "store at room temperature||refrigerate||keep tightly closed||keep in a dry place||protect from excessive moisture"
    },
    {
        "generic_name": "Glimepiride",
        "brand_name": "Amaryl||Glador",
        "disease_name": "Type 2 Diabetes Mellitus",
        "indication": "high blood sugar",
        "active_ingredients": "Glimepiride",
        "pharmaceutical_form": "tablet",
        "manufacturer": "Lupin Limited",
        "administration_route": "oral",
        "recommended_usage": "take with food||swallowed with water",
        "single_dose": "adults 1 mg",
        "dosage_frequency": "once daily",
        "mechanism_of_action": "helps your body respond better to insulin produced by your pancreas",
        "side_effects": "Dizziness||Asthenia||Headache||Nausea||severe skin rash||itching||redness||irritation||pale skin||easy bruising||bleeding||fever||unusual weakness||upper stomach pain||low fever||jaundice||vomiting||loss of appetite||restless||irritable||confusion||hallucinations||muscle pain||muscle weakness||seizure||tired feeling||stomach pain||diarrhea||increased skin sensitivity to sunlight",
        "activation_conditions": "no special condition",
        "prescription_status": "prescription_only",
        "unsuitable_population": "patients hypersensitive to glimepiride||patients hypersensitive to other sulfonylureas||patients hypersensitive to other sulfonamides||patients with type I diabetes mellitus||patients with diabetic ketoacidosis||patients with diabetic precoma or coma||pregnant women||nursing women",
        "storage_conditions": ""
    },
    {
        "generic_name": "Nebivolol",
        "brand_name": "",
        "disease_name": "Hypertension",
        "indication": "high blood pressure",
        "active_ingredients": "Nebivolol",
        "pharmaceutical_form": "tablet",
        "manufacturer": "Ascend Laboratories, LLC",
        "administration_route": "oral",
        "recommended_usage": "take with or without food",
        "single_dose": "most patients 5 mg || patients with severe renal impairment 2.5 mg || patients with moderate hepatic impairment 2.5 mg",
        "dosage_frequency": "once daily",
        "mechanism_of_action": "β-adrenergic receptor blocking; preferentially β1 selective at ≤10 mg; decreases heart rate, decreases myocardial contractility, diminishes sympathetic outflow, suppresses renin activity, vasodilation",
        "side_effects": "headache||fatigue||bradycardia||diarrhea||nausea||chest pain||peripheral edema||dizziness||insomnia||dyspnea||rash||asthenia||abdominal pain||hypercholesterolemia||paraesthesia",
        "activation_conditions": "no special condition",
        "prescription_status": "prescription_only",
        "unsuitable_population": "patients with severe bradycardia||heart block greater than first degree||patients with cardiogenic shock||decompensated cardiac failure||sick sinus syndrome (unless a permanent pacemaker is in place)||patients with severe hepatic impairment (Child-Pugh greater than B)||hypersensitive to any component of this product||children under 18",
        "storage_conditions": "store at room temperature||keep tightly closed||protect from light"
    },
    {
        "generic_name": "Flibanserin",
        "brand_name": "Fliban",
        "disease_name": "Hypoactive Sexual Desire Disorder",
        "indication": "low sexual desire||female libido disorder",
        "active_ingredients": "Flibanserin",
        "pharmaceutical_form": "tablet",
        "manufacturer": "Centurion Remedies Ltd.",
        "administration_route": "oral",
        "recommended_usage": "at fixed time",
        "single_dose": "adults 100 mg",
        "dosage_frequency": "once daily",
        "mechanism_of_action": "post-synaptic 5HT1A receptor agonist and 5HT2A receptor antagonist; regulates dopamine, norepinephrine, and serotonin",
        "side_effects": "dizziness||somnolence||nausea||fatigue||insomnia||dry mouth||anxiety||constipation||abdominal pain||metrorrhagia||rash||sedation||vertigo",
        "activation_conditions": "requires specific timing",
        "prescription_status": "",
        "unsuitable_population": "men||postmenopausal women||children||patients with hepatic impairment||patients using alcohol||patients using moderate or strong CYP3A4 inhibitors||patients with hypersensitivity to Flibanserin or any inactive ingredient",
        "storage_conditions": "store at room temperature||protect from light||keep in a dry place"
    },
    {
        "generic_name": "Ropinirole",
        "brand_name": "REQUIP||REQUIP XL",
        "disease_name": "Parkinson's disease",
        "indication": "signs and symptoms of idiopathic Parkinson's disease",
        "active_ingredients": "Ropinirole hydrochloride",
        "pharmaceutical_form": "tablet",
        "manufacturer": "GlaxoSmithKline (GSK)",
        "administration_route": "oral",
        "recommended_usage": "take with or without food",
        "single_dose": "adults 2 mg",
        "dosage_frequency": "once daily",
        "mechanism_of_action": "non-ergoline dopamine agonist",
        "side_effects": "nausea||dizziness||drowsiness||sleepiness||headache||dyskinesia||increase or decrease in blood pressure||increase or decrease in heart rate||hallucinations||gambling urges||sexual urges||other intense urges",
        "activation_conditions": "no special condition",
        "prescription_status": "prescription_only",
        "unsuitable_population": "",
        "storage_conditions": ""
    },
    {
        "generic_name": "Milnacipran",
        "brand_name": "Savella",
        "disease_name": "Fibromyalgia",
        "indication": "chronic pain||fatigue||morning stiffness||disordered sleep",
        "active_ingredients": "Milnacipran",
        "pharmaceutical_form": "tablet",
        "manufacturer": "Forest/Cypress",
        "administration_route": "oral",
        "recommended_usage": "",
        "single_dose": "adults 12.5 mg (Day 1)||adults 12.5 mg twice/d (for 2 days)||adults 25 mg twice/d (for 4 days)||adults 50 mg twice/d (for 7 days)||adults 100 mg twice/d (for 7 days)",
        "dosage_frequency": "twice a day",
        "mechanism_of_action": "serotonin and norepinephrine reuptake inhibitor",
        "side_effects": "nausea||constipation||hot flushing||dizziness||palpitations||hyperhidrosis||hypertension||vomiting||tachycardia||migraine||dry mouth||headache",
        "activation_conditions": "no special condition",
        "prescription_status": "prescription_only",
        "unsuitable_population": "patients with severe psychiatric illness",
        "storage_conditions": ""
    }
]